Posted 5th June 2019 by Joshua Broomfield
Denise Anderson is president of the Health Information Sharing and Analysis Centre (H-ISAC), USA. She spoke to us about her perspective on Healthcare Cybersecurity, the value of information sharing, and the paradigm shift the industry requires in light of new risks brought about by rapid innovation.
Posted 26th April 2019 by Joshua Broomfield
Alongside my primary role as a Project Manager, I have since 2016 been the Roche lead for the IMI industry collaboration called EHR4CR. EHR4CR is a group of roughly 10 pharma companies, universities, and SMEs working together to leverage the great wealth of information from hospitals in order to support our clinical trials and promote innovative research. It was a 7-year $16 million project.
Posted 1st April 2019 by Joshua Broomfield
This is the second instalment of a two-part blog post from Jothi Dugar, one of the pioneers in the field of Cyber Security. Here, Jothi explains how her experience with integrative medicine has transformed her approach to Cyber Security in a healthcare setting.
Posted 25th March 2019 by Joshua Broomfield
This is the first instalment of a two-part blog post from Jothi Dugar, one of the pioneers in the field of Cyber Security. Here, Jothi shares her experience of Cyber Security and developing an Information Security Office in a healthcare setting.
Posted 4th March 2019 by Joshua Broomfield
Application of blockchain is no longer a concept known only to a few industries. What started with cryptocurrency in 2009 has come a long way since. Its capability for secure transactions has enabled it to find potential in industries such as banking where security is one of key concerns when it comes to digital transformation. Healthcare industry leaders are also waking up to this call and are now exploring ways to embrace the technology owing to the multiple possible use cases for the industry.
Failing Blockbuster Medicines, Eroding Operator Margins & Increased Pricing Pressures: What’s Next for Precision Medicine?
Posted 12th September 2018 by Jane Williams
The Precision Medicine and Biomarkers Leaders Summit: Europe takes place this week and in anticipation, we spoke to Unmesh Lal of Frost and Sullivan about his views on what the future holds for precision medicine and how the pharmaceutical industry has changed in recent times.
Posted 13th August 2018 by Jane Williams
The blockchain has the potential to enable the collaboration between patients, researchers, and care providers to provide individualised care for patients, but how can this technology be harnessed in a practical way?
This was one of the key questions that was asked at the Blockchain in Healthcare Congress and we had the pleasure of welcoming an array of expert speakers from pharma, academia, and industry to provide the answer.
Posted 21st May 2018 by Jane Williams
An inquiry by the House of Lords’ Science & Technology Committee has identified several issues that could hamper the delivery of the Life Sciences Industrial Strategy vision1. The critical report (Life Sciences Industrial Strategy: Who’s driving the bus? 1) brings together evidence from industry, academia and the NHS. It highlights several implementation challenges which require “prompt and vigorous action by the government” to ensure that the scope of Life Sciences Industrial Strategy can be achieved.